What are new opportunities for clinical practice the VERIFY study opens and which values for native diabetes patients? Joint conclusion on the advisory board results. November 6, 2019
According to key diabetic studies, the early use of metformin glucose lowering therapy is associated with a reduced risk of developing micro- and, in the long term, 10-year follow-up, macrovascular complications and cardiovascular mortality. Short-term studies results on combined glucose lowering th...
Guardado en:
Autores principales: | Marina V. Shestakova, Mikhail B. Antsiferov, Alexander S. Ametov, Gagik R. Galstyan, Tatiana Y. Demidova, Alexey V. Zilov, Tatiana N. Markova, Nina A. Petunina, Natalya A. Chernikova, Minara S. Shamkhalova |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ce89e3c8673e4cb8b05e23404c86d100 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Results of a clinical trial of the efficacy and safety of vildagliptin and metformin fixed combination in real clinical practice in Russia (MASTER study)
por: N. A. Demidov, et al.
Publicado: (2021) -
EDGE study in Russian Federation: efficacy and safety of vildagliptine in comparison with other oral antidiabetic agents in patients with type 2 diabetes mellitus
por: Gagik Radikovich Galstyan
Publicado: (2013) -
The efficacy of therapy with DPP-4 inhibitors combined with insulin in patients with type 2 diabetes mellitus
por: Alexander Sergeevich Ametov, et al.
Publicado: (2011) -
Possible applications of gliptins (dipeptidyl peptidase-4 inhibitors) in patients with type 2 diabetes mellitus on the various modes of insulin therapy
por: Gagik Radikovich Galstyan, et al.
Publicado: (2015) -
Long-Term Glycaemic Durability of Early Combination Therapy Strategy versus Metformin Monotherapy in Korean Patients with Newly Diagnosed Type 2 Diabetes Mellitus
por: Soon-Jib Yoo, et al.
Publicado: (2021)